Drugs News and Research

RSS

Catheter ablation improves quality of life for adults with atrial fibrillation

Adults who undergo a minimally invasive technique to treat atrial fibrillation are significantly less likely to die from a heart attack or heart failure, according to a long-term study by the University of Michigan Frankel Cardiovascular Center.

30 Jul 2014

First Edition: July 30, 2014

Today's headlines include a range of health policy headines, including news from Capitol Hill on the Senate confirmation of Robert McDonald to head the VA.

30 Jul 2014

Study: Socialization emerges as relative strength in boys with fragile X

Standard scores measuring "adaptive behavior" in boys with fragile X syndrome tend to decline during childhood and adolescence, the largest longitudinal study of the inherited disorder to date has found.

30 Jul 2014

Adolescents get better care when health care visit is confidential, say researchers

Teens who have the option to privately and confidentially discuss health concerns with their doctor are more likely to talk about reproductive health, mental health, issues at school, and some self-care topics than they would be in discussions where a parent is present, finds a new study in the Journal of Adolescent Health.

30 Jul 2014

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME).

29 Jul 2014

Cloud Pharmaceuticals awarded Phase I grant from NSF SBIR program

Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, announced today that it has been awarded a Phase I grant from the National Science Foundation Small Business Innovation Research program.

29 Jul 2014

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.

29 Jul 2014

Kurbo program launched to tackle childhood obesity epidemic using mobile tools

Kurbo Health today announced the launch of Kurbo, the first safe and effective program to tackle the childhood obesity epidemic using mobile tools. For the first time, children, teens and their parents have access to a safe, effective and proven mobile platform for losing weight.

29 Jul 2014

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

Two new pill-only antiviral drug regimens could provide shorter, more effective treatment options with fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, according to the results of two studies published in The Lancet.

29 Jul 2014

Viewpoints: GOP's 'political sideshow;' Boehner says House must defend the constitution; Jonathan Gruber on center stage about subsidies

This week, before the House leaves for its August recess, the GOP majority is expected to approve a lawsuit against Obama.

29 Jul 2014

Biochemists report advance in production of functional mirror-image proteins

University of Utah biochemists have reported an advance in the production of functional mirror-image proteins.

29 Jul 2014

Hardship exemptions allow some to continue to buy coverage on health law's marketplaces

Elsewhere, the San Jose Mercury News examines who can opt out of the health law's mandate to have insurance on religious grounds.

29 Jul 2014

Findings reveal new way to identify non-antibiotic drugs that could help curb bacterial infections

About 100 drugs already approved by the U.S. Food and Drug Administration (FDA) for other purposes can also prevent the growth of certain bacterial pathogens inside human cells, including those that cause Legionnaires' disease, brucellosis, and Mediterranean spotted fever.

29 Jul 2014

Researchers one step closer to finding treatment for Alzheimer's, other forms of dementia

There is no cure for Alzheimer's disease and other forms of dementia, but the research community is one step closer to finding treatment.

29 Jul 2014

Research points to new direction for potential therapies to treat mucoepidermoid carcinoma

Research conducted at the Florida campus of The Scripps Research Institute has discovered links between a set of genes known to promote tumor growth and mucoepidermoid carcinoma, an oral cancer that affects the salivary glands. The discovery could help physicians develop new treatments that target the cancer's underlying genetic causes.

29 Jul 2014

PLXNA4 gene may increase risk of developing Alzheimer's disease

Researchers from Boston University School of Medicine report variants in a new gene, PLXNA4, which may increase the risk of developing Alzheimer's disease (AD). The discovery of this novel genetic association may lead to new drug treatment options that target PLXNA4 specifically.

28 Jul 2014

Psychemedics' Q2 revenue increases 12% to $7.7 million

Psychemedics Corporation today announced second quarter financial results for the period ended June 30, 2014. The Company also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of August 7, 2014 to be paid on August 18, 2014.

28 Jul 2014

Cardioxyl reports positive results from CXL-1427 Phase I trial for treatment of ADHF

Cardioxyl Pharmaceuticals, Inc. announced today the positive results of a clinical trial demonstrating that CXL-1427, a novel potential treatment for acute decompensated heart failure (ADHF), was well tolerated in healthy volunteers.

28 Jul 2014

New study in recognition of World Hepatitis Day released on Life Sciences Connect

The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today released a new study in recognition of World Hepatitis Day on Life Sciences Connect, a blog exploring the latest news and trends in Life Sciences and updates on the drug pipeline identifying multiple treatments in development that may serve as potential alternatives to Gilead's Sovaldi, currently priced in the United States at $84,000 for 12 weeks of treatment - $1000 per pill.

28 Jul 2014

Antifungal drug resistance evoked through RNAi-dependent epimutations

Microorganisms like bacteria and fungi can evade treatment by acquiring mutations in the genes targeted by antibiotics or antifungal drugs.

27 Jul 2014

Drugs News and Research

Catheter ablation improves quality of life for adults with atrial fibrillation

First Edition: July 30, 2014

Study: Socialization emerges as relative strength in boys with fragile X

Adolescents get better care when health care visit is confidential, say researchers

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

Cloud Pharmaceuticals awarded Phase I grant from NSF SBIR program

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

Kurbo program launched to tackle childhood obesity epidemic using mobile tools

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

Viewpoints: GOP's 'political sideshow;' Boehner says House must defend the constitution; Jonathan Gruber on center stage about subsidies

Biochemists report advance in production of functional mirror-image proteins

Hardship exemptions allow some to continue to buy coverage on health law's marketplaces

Findings reveal new way to identify non-antibiotic drugs that could help curb bacterial infections

Researchers one step closer to finding treatment for Alzheimer's, other forms of dementia

Research points to new direction for potential therapies to treat mucoepidermoid carcinoma

PLXNA4 gene may increase risk of developing Alzheimer's disease

Psychemedics' Q2 revenue increases 12% to $7.7 million

Cardioxyl reports positive results from CXL-1427 Phase I trial for treatment of ADHF

New study in recognition of World Hepatitis Day released on Life Sciences Connect

Antifungal drug resistance evoked through RNAi-dependent epimutations

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News